Meta-Analysis
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Nov 21, 2024; 30(43): 4636-4656
Published online Nov 21, 2024. doi: 10.3748/wjg.v30.i43.4636
Prevalence of Helicobacter pylori infection in China from 2014-2023: A systematic review and meta-analysis
Lu Xie, Guang-Wei Liu, Ya-Nan Liu, Peng-Yu Li, Xin-Ning Hu, Xin-Yi He, Rui-Bo Huan, Tai-Long Zhao, Hui-Jun Guo
Lu Xie, Ya-Nan Liu, Peng-Yu Li, Xin-Ning Hu, Xin-Yi He, Rui-Bo Huan, Tai-Long Zhao, Hui-Jun Guo, Department of Acquired Immune Deficiency Syndrome Treatment and Research Center, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, Henan Province, China
Lu Xie, Ya-Nan Liu, Xin-Ning Hu, Xin-Yi He, Rui-Bo Huan, Tai-Long Zhao, The First Clinical Medical School, Henan University of Chinese Medicine, Zhengzhou 450046, Henan Province, China
Guang-Wei Liu, Department of Spleen, Stomach, Liver and Gallbladder, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, Henan Province, China
Peng-Yu Li, Hui-Jun Guo, Henan Key Laboratory of Viral Diseases Prevention and Treatment of Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou 450000, Henan Province, China
Author contributions: Xie L designed the study and edited the manuscript; Xie L and Liu GW reviewed papers and extracted relevant data; Li PY resolved disagreements; Hu XN and He XY conducted data cross checking; Xie L and Liu YN performed statistical analysis and wrote the manuscript; Li PY, Huan RB and Zhao TL provided comments or suggestions about the manuscript; Guo HJ guided the writing and editing of the article, had primary responsibility for final content; all of the authors read and approved the final version of the manuscript to be published.
Supported by The Zhongyuan Famous Doctor, No. ZYYCYU202012119; Scientific Research Special Project of Traditional Chinese Medicine in Henan Province, No. 2024ZY2004; and Scientific Research Special Project of the National TCM Inheritance and Innovation Center of Henan Provincial Health Commission, No. 2023ZXZX1093.
Conflict-of-interest statement: The authors disclose that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hui-Jun Guo, PhD, Professor, Department of Acquired Immune Deficiency Syndrome Treatment and Research Center, The First Affiliated Hospital of Henan University of Chinese Medicine, No. 19 Renmin Road, Jinshui District, Zhengzhou 450000, Henan Province, China. guohuijun@hactcm.edu.cn
Received: July 3, 2024
Revised: September 19, 2024
Accepted: October 16, 2024
Published online: November 21, 2024
Processing time: 120 Days and 9.6 Hours
Core Tip

Core Tip: Globally, Helicobacter pylori infection continues to be the most prevalent infectious disease, posing substantial public health challenges. Despite a reduction in overall prevalence to 42.8% over the past decade, high rates persist in specific areas and demographics within China, necessitating continued vigilance and targeted interventions.